ESC 365 - APOLLO - Apixaban for prophylaxis of thromboembolic outcomes in COVID-19.

ESC Professional Premium Access

APOLLO - Apixaban for prophylaxis of thromboembolic outcomes in COVID-19.

Session: Latest science in COVID and vaccination

Topic: Anticoagulants

Speaker: Professor R. Lopes (Durham, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)

24 presentations

0 follower

2 more presentations in this session

Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination.

Speaker: Professor C. Mueller (Basel, CH)

Influenza Vaccine Among Patients with Acute Coronary Syndromes: the VIP-ACS trial .

Speaker: Doctor R. Furtado (Sao Paulo, BR)

Access the full session

Latest science in COVID and vaccination

Speakers: Professor R. Lopes, Professor C. Mueller, Doctor R. Furtado

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources